WO1998051308A1
(en)
*
|
1997-05-13 |
1998-11-19 |
Octamer, Inc. |
METHODS FOR TREATING INFLAMMATION AND INFLAMMATORY DISEASES USING pADPRT INHIBITORS
|
US6291511B1
(en)
|
1997-05-29 |
2001-09-18 |
Merck & Co., Inc. |
Biarylalkanoic acids as cell adhesion inhibitors
|
US6221888B1
(en)
|
1997-05-29 |
2001-04-24 |
Merck & Co., Inc. |
Sulfonamides as cell adhesion inhibitors
|
US5922719A
(en)
*
|
1997-08-11 |
1999-07-13 |
Warner-Lambert Company |
Coumarin dopamine D4 receptor antagonists
|
US6069163A
(en)
*
|
1997-10-21 |
2000-05-30 |
Merck & Co., Inc. |
Azapeptide acids as cell adhesion inhibitors
|
US6020347A
(en)
*
|
1997-11-18 |
2000-02-01 |
Merck & Co., Inc. |
4-substituted-4-piperidine carboxamide derivatives
|
US6191171B1
(en)
|
1997-11-20 |
2001-02-20 |
Merck & Co., Inc. |
Para-aminomethylaryl carboxamide derivatives
|
US6090841A
(en)
*
|
1997-11-21 |
2000-07-18 |
Merck & Co., Inc. |
Substituted pyrrole derivatives as cell adhesion inhibitors
|
US6645939B1
(en)
|
1997-11-24 |
2003-11-11 |
Merck & Co., Inc. |
Substituted β-alanine derivatives as cell adhesion inhibitors
|
KR20010042804A
(en)
*
|
1998-04-17 |
2001-05-25 |
파커 휴우즈 인스티튜트 |
Btk inhibitors and methods for their identification and use
|
US6303652B1
(en)
|
1998-08-21 |
2001-10-16 |
Hughes Institute |
BTK inhibitors and methods for their identification and use
|
FR2781153B1
(en)
*
|
1998-07-15 |
2001-08-03 |
Lafon Labor |
FLAVONOID-BASED THERAPEUTIC COMPOSITION FOR USE IN THE TREATMENT OF TUMORS WITH CYTOTOXIC AGENTS
|
DE19845372A1
(en)
*
|
1998-10-02 |
2000-04-20 |
Gruenenthal Gmbh |
Use of catechol derivatives as proteinase inhibitors
|
HUP0104607A3
(en)
*
|
1998-12-15 |
2002-12-28 |
Warner Lambert Co |
Use of a mek inhibitor for preventing transplant rejection
|
US6291456B1
(en)
|
1998-12-30 |
2001-09-18 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
US6331562B1
(en)
|
1998-12-30 |
2001-12-18 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
WO2000050030A1
(en)
*
|
1999-02-25 |
2000-08-31 |
Ted Ebendal |
New use
|
AU2001278980A1
(en)
*
|
2000-07-21 |
2002-02-05 |
Chugai Seiyaku Kabushiki Kaisha |
Coumarin derivatives useful as tnfalpha inhibitors
|
EP1368024A4
(en)
*
|
2001-03-16 |
2009-03-18 |
Novogen Res Pty Ltd |
Treatment of restenosis
|
KR20020096367A
(en)
*
|
2001-06-19 |
2002-12-31 |
주식회사 티지 바이오텍 |
Pharmaceutical composition for the prevention and treatment of arthritis having effect of essential treatment and a method for screening it
|
KR20020096368A
(en)
*
|
2001-06-19 |
2002-12-31 |
주식회사 티지 바이오텍 |
Mass cell production method of chondrocytes by the inhibition of de-differentiation and a method for screening it
|
AR038136A1
(en)
|
2002-01-24 |
2004-12-29 |
Merck Frosst Canada Inc |
CYCLALCANINDOLS WITH REPLACEMENT WITH FLUOR COMPOSITIONS CONTAINING THESE COMPOUNDS AND TREATMENT METHODS
|
JP4587652B2
(en)
*
|
2002-09-09 |
2010-11-24 |
株式会社フラバミン |
Novel flavonoid compounds and their use
|
AU2003267245C1
(en)
|
2002-09-20 |
2008-05-29 |
Promega Corporation |
Luminescence-based methods and probes for measuring cytochrome P450 activity
|
EP1556031A4
(en)
*
|
2002-10-22 |
2009-03-25 |
Jenken Biosciences Inc |
Chromones and chromone derivatives and uses thereof
|
CA2503720A1
(en)
|
2002-10-30 |
2004-05-21 |
Merck & Co., Inc. |
Gamma-aminoamide modulators of chemokine receptor activity
|
EP1644006A1
(en)
*
|
2003-05-28 |
2006-04-12 |
Université de Liège |
Pharmaceutical composition for the treatment and/or the prevention of atherosclerosis from infectious origin
|
BRPI0509803A
(en)
|
2004-04-13 |
2007-09-18 |
Incyte Corp |
piperazinylpiperidine derivatives as chemokine receptor antagonists
|
EP3312292B1
(en)
*
|
2005-05-31 |
2019-09-25 |
Promega Corporation |
Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
|
CA2617728A1
(en)
*
|
2005-07-15 |
2007-01-25 |
Sahajanand Biotech Private Limited |
Implantable medical devices comprising a flavonoid or derivative thereof for prevention of restenosis
|
US8410109B2
(en)
*
|
2005-07-29 |
2013-04-02 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
MEP1008A
(en)
|
2005-12-21 |
2010-02-10 |
Incyte Corp |
3-aminocyclopentanecarboxamides as modulators of chemokine receptors
|
CN1837202B
(en)
*
|
2006-04-25 |
2010-08-18 |
中国人民解放军第二军医大学 |
Flavonols with blood-fat-lowering effect
|
US8053440B2
(en)
|
2007-02-01 |
2011-11-08 |
Resverlogix Corporation |
Compounds for the prevention and treatment of cardiovascular diseases
|
WO2009118338A2
(en)
*
|
2008-03-27 |
2009-10-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of a polyphenolic type compound for preventing or treating a polyglutamine expansion neurodegenerative disease
|
CA2711103C
(en)
|
2008-06-26 |
2016-08-09 |
Resverlogix Corp. |
Methods of preparing quinazolinone derivatives
|
JP5597200B2
(en)
|
2008-08-18 |
2014-10-01 |
プロメガ コーポレイション |
Compounds producing luminescence and methods for detecting cytochrome P4503A enzyme
|
AU2009295230A1
(en)
|
2008-09-22 |
2010-03-25 |
Merck Canada Inc. |
Indole derivatives as CRTH2 receptor antagonists
|
JP5611957B2
(en)
*
|
2008-09-29 |
2014-10-22 |
サートリス ファーマシューティカルズ, インコーポレイテッド |
Quinazolinones, quinolones and related analogs as sirtuin modulators
|
EP2910945B1
(en)
|
2008-09-30 |
2018-07-18 |
Case Western Reserve University |
Molecular probes for imaging of myelin
|
WO2010061329A1
(en)
|
2008-11-26 |
2010-06-03 |
Pfizer Inc. |
3-aminocyclopentanecarboxamides as chemokine receptor modulators
|
AU2010204106B2
(en)
|
2009-01-08 |
2014-05-08 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular disease
|
AU2010210986A1
(en)
|
2009-02-09 |
2011-08-25 |
Supergen, Inc. |
Pyrrolopyrimidinyl Axl kinase inhibitors
|
WO2010099039A1
(en)
|
2009-02-24 |
2010-09-02 |
Merck Sharp & Dohme Corp. |
Indole derivatives as crth2 receptor antagonists
|
KR101913109B1
(en)
|
2009-03-18 |
2018-10-31 |
리스버로직스 코퍼레이션 |
Novel anti-inflammatory agents
|
TR201818390T4
(en)
|
2009-04-22 |
2019-01-21 |
Resverlogix Corp |
NEW ANTI-INFLAMMATORY AGENTS
|
WO2012051036A1
(en)
|
2010-10-11 |
2012-04-19 |
Merck Sharp & Dohme Corp. |
Quinazolinone-type compounds as crth2 antagonists
|
MX2013007295A
(en)
|
2010-12-23 |
2013-08-26 |
Merck Sharp & Dohme |
Quinoxalines and aza-quinoxalines as crth2 receptor modulators.
|
KR20140025500A
(en)
|
2011-05-04 |
2014-03-04 |
머크 샤프 앤드 돔 코포레이션 |
Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
|
CN102274237B
(en)
*
|
2011-06-16 |
2012-12-05 |
成都中医药大学 |
Novel application of flavonoid compound
|
AU2012271661B8
(en)
|
2011-06-17 |
2016-11-10 |
Merck Sharp & Dohme Corp. |
Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulators
|
EP2763975B1
(en)
|
2011-10-05 |
2016-04-06 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
KR102011641B1
(en)
|
2011-11-01 |
2019-08-19 |
리스버로직스 코퍼레이션 |
Oral immediate release formulations for substituted quinazolinones
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
WO2014080290A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Cyclic amines as bromodomain inhibitors
|
JP2016507496A
(en)
|
2012-12-21 |
2016-03-10 |
ゼニス・エピジェネティクス・コーポレイションZenith Epigenetics Corp. |
Novel heterocyclic compounds as bromodomain inhibitors
|
WO2015116867A1
(en)
|
2014-01-29 |
2015-08-06 |
Promega Corporation |
Quinone-masked probes as labeling reagents for cell uptake measurements
|
US9840488B2
(en)
*
|
2015-01-26 |
2017-12-12 |
Utah State University |
Carbon monoxide releasing molecules and associated methods
|
GB2585171B
(en)
|
2015-02-19 |
2021-03-24 |
Council Scient Ind Res |
An antioxidant compound having anti atherosclerotic effect and preparation thereof
|
KR20170123696A
(en)
|
2015-03-13 |
2017-11-08 |
리스버로직스 코퍼레이션 |
Composition and method for treating complement related diseases
|
KR101837690B1
(en)
*
|
2016-04-04 |
2018-03-13 |
한국한의학연구원 |
Compostion for prevention or treatment restenosis comprising Alpinia officinarum Hance extracts, fractions or galangin seperated from therefrom
|
DE102016223763A1
(en)
*
|
2016-11-30 |
2018-05-30 |
Beiersdorf Ag |
Use of 2'-methoxyflavone in cosmetic or dermatological preparations for the prophylaxis and treatment of sensitive skin
|
CN109265424B
(en)
*
|
2018-09-25 |
2020-08-21 |
天津中医药大学 |
Flavonoid derivative and preparation method and identification method thereof
|
EP3909952A4
(en)
|
2019-01-10 |
2023-01-25 |
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
Salts of heterocyclic compound and use thereof
|